Pitt–Hopkins Syndrome and Differential Diagnosis: A Molecular and Clinical Challenge

Abstract

Pitt–Hopkins syndrome is an emerging neurodevelopmental disorder caused by haploinsufficiency of the TCF4 gene on chromosome 18q21. It is characterized by severe intellectual disability, seizures, microcephaly, constipation and a distinctive facial gestalt. Although the overlapping phenotype of microcephaly, epilepsy, absent speech and constipation represents a challenge for the differential diagnosis with Angelman syndrome, Rett syndrome and Mowat–Wilson syndrome, distinctive of Pitt–Hopkins syndrome are breathing abnormalities, that can occur as either hyperventilation episodes or apnea crises, and a typical facial dysmorphism, including bitemporal narrowing, squared forehead, deep-set eyes, peculiar nose conformation, with broad nasal bridge, down-turned nasal tip and flaring nostrils, typical shape of the mouth, with a tented and M shaped upper lip, and widely spaced teeth. The occurrence of these signs in variable association of uncoordinated movements, microcephaly of postnatal onset, eye abnormalities, constipation, epilepsy and subtle brain abnormalities is highly predictive of a TCF4 mutation, making it possible to plan a genetic test of choice among severe encephalopathies. Angelman syndrome represents the nosological condition closest to Pitt–Hopkins syndrome.

Keywords

Pitt-Hopkins syndrome - TCF4 - differential diagnosis

• References

• 1 Pitt D, Hopkins I. A syndrome of mental retardation, wide mouth and intermittent overbreathing. Aust Paediatr J 1978; 14 (3) 182-184
• 2 Singh HA. Mental retardation, macrostomia and hyperpnoea syndrome. J Paediatr Child Health 1993; 29 (2) 156-157
• 3 Van Balkom ID, Quartel S, Hennekam RC. Mental retardation, “coarse” face, and hyperbreathing: confirmation of the Pitt-Hopkins syndrome. Am J Med Genet 1998; 75 (3) 273-276
• 4 Orrico A, Galli L, Zappella M , et al. Possible case of Pitt-Hopkins syndrome in sibs. Am J Med Genet 2001; 103 (2) 157-159
• 5 Peippo MM, Simola KO, Valanne LK , et al. Pitt-Hopkins syndrome in two patients and further definition of the phenotype. Clin Dysmorphol 2006; 15 (2) 47-54
• 6 Amiel J, Rio M, de Pontual L , et al. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet 2007; 80 (5) 988-993
• 7 Zweier C, Peippo MM, Hoyer J , et al. Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 2007; 80 (5) 994-1001
• 8 Brockschmidt A, Todt U, Ryu S , et al. Severe mental retardation with breathing abnormalities (Pitt-Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4. Hum Mol Genet 2007; 16 (12) 1488-1494
• 9 Zweier C, Sticht H, Bijlsma EK , et al. Further delineation of Pitt-Hopkins syndrome: phenotypic and genotypic description of 16 novel patients. J Med Genet 2008; 45 (11) 738-744
• 10 Andrieux J, Lepretre F, Cuisset JM , et al. Deletion 18q21.2q21.32 involving TCF4 in a boy diagnosed by CGH-array. Eur J Med Genet 2008; 51 (2) 172-177
• 11 Giurgea I, Missirian C, Cacciagli P , et al. TCF4 deletions in Pitt-Hopkins syndrome. Hum Mutat 2008; 29 (11) E242-E251
• 12 Rosenfeld JA, Leppig K, Ballif BC , et al. Genotype-phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations. Genet Med 2009; 11 (11) 797-805
• 13 de Pontual L, Mathieu Y, Golzio C , et al. Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome. Hum Mutat 2009; 30 (4) 669-676
• 14 Takano K, Lyons M, Moyes C, Jones J, Schwartz CE. Two percent of patients suspected of having Angelman syndrome have TCF4 mutations. Clin Genet 2010; 78 (3) 282-288
• 15 Marangi G, Ricciardi S, Orteschi D , et al. The Pitt-Hopkins syndrome: report of 16 new patients and clinical diagnostic criteria. Am J Med Genet A 2011; 155A (7) 1536-1545
• 16 Marangi G, Ricciardi S, Orteschi D , et al. Proposal of a clinical score for the molecular test for Pitt-Hopkins syndrome. Am J Med Genet A 2012; 158A (7) 1604-1611
• 17 Whalen S, Héron D, Gaillon T , et al. Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum. Hum Mutat 2012; 33 (1) 64-72
• 18 Sweatt JD. Pitt-Hopkins syndrome: intellectual disability due to loss of TCF4-regulated gene transcription. Exp Mol Med 2013; 45: e21
• 19 Sepp M, Kannike K, Eesmaa A, Urb M, Timmusk T. Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5′ exon usage and splicing. PLoS ONE 2011; 6 (7) e22138
• 20 Forrest MP, Hill MJ, Quantock AJ, Martin-Rendon E, Blake DJ. The emerging roles of TCF4 in disease and development. Trends Mol Med 2014; 20 (6) 322-331
• 21 Sepp M, Pruunsild P, Timmusk T. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects. Hum Mol Genet 2012; 21 (13) 2873-2888
• 22 Stefansson H, Ophoff RA, Steinberg S , et al; Genetic Risk and Outcome in Psychosis (GROUP). Common variants conferring risk of schizophrenia. Nature 2009; 460 (7256) 744-747
• 23 Ellinghaus D, Folseraas T, Holm K , et al. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology 2013; 58 (3) 1074-1083
• 24 Baratz KH, Tosakulwong N, Ryu E , et al. E2-2 protein and Fuchs's corneal dystrophy. N Engl J Med 2010; 363 (11) 1016-1024
• 25 Kalscheuer VM, Feenstra I, Van Ravenswaaij-Arts CM , et al. Disruption of the TCF4 gene in a girl with mental retardation but without the classical Pitt-Hopkins syndrome. Am J Med Genet A 2008; 146A (16) 2053-2059
• 26 Zweier C, de Jong EK, Zweier M , et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 2009; 85 (5) 655-666
• 27 Harrison V, Connell L, Hayesmoore J, McParland J, Pike MG, Blair E. Compound heterozygous deletion of NRXN1 causing severe developmental delay with early onset epilepsy in two sisters. Am J Med Genet A 2011; 155A (11) 2826-2831
• 28 Kato Z, Morimoto W, Kimura T, Matsushima A, Kondo N. Interstitial deletion of 18q: comparative genomic hybridization array analysis of 46, XX,del(18)(q21.2.q21.33). Birth Defects Res A Clin Mol Teratol 2010; 88 (2) 132-135